Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 430 (TSX: $VLNS.TO)
(CSE: $IMCC.C) (TSXV: $WMD.V) (OTCQX: $WDDMF)
Delta, Kelowna, BC, June 18, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/06181VLNS-IMCC-WMD-WDDMF.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public and private company announcements.
Valens
GroWorks Corp. (TSX:
VLNS) (OTCQX:
VLNCF), a global
leader in the end-to-end development and manufacturing of innovative,
cannabinoid-based products, today
announced that it has signed a custom manufacturing agreement
with Vancouver-based boutique brand house, FPS Brands Inc., to launch ufeelu, a
line of craft, hemp-derived CBD products.
Under the terms of the two-year
agreement, The Valens Company has agreed to manufacture a minimum of 250,000
units across a variety of branded products in the ufeelu portfolio. Valens will
initially focus on the development of cannabis oils, vapes and topicals, with
specialty drinks expected to be added to the product line shortly. The Valens
Company will be responsible for providing premium extracts, filling, packaging
and manufacturing services, in addition to national distribution of the ufeelu
branded products. Fees equal to the predetermined wholesale price will be
earned by The Valens Company for all branded products manufactured, shipped,
and sold, in addition to a brokerage fee on monthly revenue. FPS Brands will
receive revenue upon the sale of products to provincial cannabis regulators. A
minimum production deposit will be provided upfront by FPS Brands.
FPS Brands is a Vancouver-based
boutique brand house focused on creating innovative and approachable
cannabinoid-based products. The ufeelu product line uses Canadian-grown hemp
and carefully selected plant-based terpenes to craft naturally enhanced broad
spectrum CBD blends in various consumable methods. The low THC line of products
is designed for those who want to embrace whole plant extracts without the
psychoactive effects.
"We are excited to launch
ufeelu with our new partner FPS Brands, a fellow Western Canadian company
focused on crafting artisanal CBD products," said Tyler Robson, CEO of The
Valens Company. "Their ability to dream up original brands such as ufeelu
perfectly complements our expertise in using plant-based science to create
customizable oil-based products. The ufeelu line will leverage Valens' vast
terpene database, in addition to botanical extracts, to bring these
meaningfully curated CBD products to Canadian consumers in fall 2020."
IM
Cannabis Corp. (CSE:IMCC), one
of the world's pioneering medical cannabis companies with operations in Israel
and across Europe, announced that
Focus Medical Herbs Ltd. has successfully received its first shipment of
medical cannabis from an EU-GMP certified indoor cultivator of medical cannabis
based in Canada. This first shipment is comprised of approximately 200kg of
medical cannabis and will be sold by Focus Medical under the IMC brand to
medical patients in Israel.
IMC has now secured seven suppliers
producing under the IMC brand: five domestic suppliers in Israel, and EU-GMP
suppliers in both Spain and Canada. With the Israeli government now accepting
applications for export of medical cannabis, this supply base could be used to
fulfill the growing demand in the European market subject to regulatory
approval. Furthermore, the first shipment of 200kg of medical cannabis from
Focus Medical's EU-GMP supply partner in Spain is being sold under its
previously announced pharmacy sales agreements and is receiving positive
reviews. The next shipments from Spain to Israel are expected in the third
quarter.
"We have great respect for
Canada's global leadership in the development of its local and international
cannabis industries. With our ambition for IMC to become a leading global brand
in medical cannabis, it is a strategic imperative to have deep ties with
Canadian licensed producers," said Oren Shuster, Chief Executive Officer
of IMC. "The outlook for the cannabis industry in Israel is very promising
following the Israeli government's announcement last week of its intention to
develop a cannabis decriminalization framework with legislation to increase
access to cannabis for more users across the country. We are very confident
that this will result in increased demand for high quality cannabis products as
more users access cannabis through legal channels as we have seen in North
America. IMC remains in an excellent position to increase its brand's market
share in Israel and expand its international recognition by providing cannabis
products known for quality, consistency and purity."
WeedMD
Inc.
(TSX-V:WMD) (OTCQX:WDDMF), a
federally licensed producer and distributor of medical-grade cannabis, announced the
launch of its same-day medical cannabis home delivery service. The pilot
project called ‘PatientDirect’ will service local patients in the greater
Toronto-area starting in June, with order fulfillment from the Company’s
Bowmanville, Ontario distribution centre located just outside Toronto.
PatientDirect is intended to ease
potential third-party postal and delivery service disruptions
resulting from the current business
conditions. The service will be offered to new and existing Starseed Medicinal
patients commencing in June with eligible patients being notified by email. The
service will expand to WeedMD patients in the coming weeks. Over time it is
expected to become a standard service option.
“Expanding our in-house delivery
options for more timely transport to our medical patients was a strategic goal
for the year which we recently accelerated as an immediate solution to
potential postal delays,” said Angelo Tsebelis, CEO of WeedMD. “By centralizing
a medical fulfillment operation in our Bowmanville processing centre, we can
fast-track deliveries to patients in the greater Toronto area. Launching
PatientDirect required thoughtful planning and resource allocation and I’m
proud of our team for expediting this to better serve our patients’ needs and
add long term value to our offerings.”
“Ensuring our patients have reliable
access to medical cannabis through a trusted and safe delivery system is
paramount for promoting health and wellness in our community,” said Moe Jiwan,
Chief Customer Officer, WeedMD and Starseed. “After listening to our patient’s
feedback, it was clear there was a need for a more reliable, safe, and speedy
delivery option and we’re thrilled to confirm the launch of our PatientDirect
service.”
As part of its ongoing rapid
expansion across Ontario, The Hunny Pot
Cannabis Co. announced the
launch of its first express cannabis stores, located in the heart of the Yonge
and Eglinton neighbourhood.
The two new express stores are
located at 2591 Yonge St and 2103 Yonge St and will depart from The Hunny Pot’s
original concept and layout of the brands flagship stores in favour of
contactless, express models that reduce the need for person to person
contact. The two new locations will mark
the brands third and fourth locations and is the first cannabis retail store
for the community.
The move to a more digital,
contactless framework is on par with industry trends across the globe.
“There’s been a significant drive
for many industries to offer a more intuitive framework that focuses on
customer experience and efficiency first and foremost,” said Hunny Gawri, Owner
of The Hunny Pot Cannabis Co. “The Hunny Pot flagship stores are larger in
format and focus on enhancing the retail experience from all angles, including
personalized budtenders, but as digital technologies are changing the way
consumers shop, we opted for a smaller, more flexible format with these express
stores.”
Both stores will also offer the
popular curbside pickup and same day delivery that was launched by The Hunny
Pot in April 2020. The Hunny Pot is now offering same day delivery starting at
$0 to customers in Toronto and Hamilton.
“We’ve already seen these express
models being adapted successfully in grocery stores, restaurants and hotels,
and we are excited to be applying this format to the cannabis space. Our
customers can expect the same quality and customer service they have come to
know from our brand, but with a smaller footprint and improvements made to
allow for a quicker, expedited retail experience,” said Hunny Gawri.
In light of the ongoing COVID-19
pandemic, the store comes at a time that consumers are looking for safer and
more innovative ways to shop.
“This express concept was in the
works well before the pandemic hit, but it’s evident that it’s come at the
right time. The pandemic has really reinforced that the way we shop is changing
and is going to continue to change,” said Hunny Gawri.
“While it's not a conventional
approach to secure two stores so close to one another, there is a considerably
high demand for legal cannabis in this area. Our hope is that with two
locations in such close proximity, we will be in a strong position to better
service the neighbourhood in less time, ultimately helping more customers
experience legal cannabis in a safe and welcoming space,” said Hunny Gawri.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com website
and that this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
